Blood Preparation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Blood Preparation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

The global blood preparation market size reached US$ 40.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 53.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.

Blood Preparation Market Trends:
Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.

Breakup by Product:

Whole Blood
Red Cells
Granulocytes
Plasma
Platelets
Blood Components
Whole Blood Components
Packed Red Cells
Leukocyte Reduced Red Blood Cells
Frozen Plasma
Platelet Concentrate
Cryoprecipitate
Blood Derivatives

Breakup by Antithrombotic and Anticoagulants Type:

Platelet Aggregation Inhibitors
Glycoprotein Inhibitors
COX Inhibitors
ADP Antagonists
Others
Fibrinolytics
Tissue Plasminogen Activator (TPA)
Streptokinase
Urokinase
Anticoagulants
Heparins
Vitamin K Antagonists
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors

Breakup by Antithrombotic and Anticoagulants Application:

Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.

Key Questions Answered in This Report:
How has the global blood preparation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global blood preparation market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the antithrombotic and anticoagulants type?
What is the breakup of the market based on the antithrombotic and anticoagulants application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global blood preparation market and who are the key players?
What is the degree of competition in the industry?